Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-09-28

FDA Approved: ROPINIROLE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved Actavis Pharma, Inc.'s supplemental application for ropinirole, a generic ropinirole product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ropinirole (ropinirole)

Snippet

SUPPL AP for ROPINIROLE (ROPINIROLE)